← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Efavirenz + emtricitabina + tenofovir disoproxil fosfato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: EFAVIRENZ + EMTRICITABINA + TENOFOVIR DISOPROXIL FOSFATO · data refreshed 9 September 2026
As of 9 September 2026, 1 of the 9 tracked registers list current availability issues for Efavirenz + emtricitabina + tenofovir disoproxil fosfato, covering 1 affected product presentation. The longest-running open report was filed in Italy on 2022-08-05 and has now been open for about 49 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL ZENTIVA | 2022-08-05 | — | Elevata richiesta: forniture discontinue Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Efavirenz + emtricitabina + tenofovir disoproxil fosfato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL ZENTIVA | Shortage | 2022-08-05 | — | Elevata richiesta: forniture discontinue |
Yes. As of 9 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Efavirenz + emtricitabina + tenofovir disoproxil fosfato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Efavirenz + emtricitabina + tenofovir disoproxil fosfato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/efavirenz-emtricitabina-tenofovir-disoproxil-fosfato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Efavirenz + emtricitabina + tenofovir disoproxil fosfato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/efavirenz-emtricitabina-tenofovir-disoproxil-fosfato/">Efavirenz + emtricitabina + tenofovir disoproxil fosfato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>